Hara Capital’s AbbVie ABBV Stock Holding History

Hara Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$767K	Hold	3,048	–	–	0.4%	66
2026 Q1	$663K	Hold	3,048	–	–	0.33%	71
2025 Q4	$696K	Hold	3,048	–	–	0.39%	64
2025 Q3	$706K	Hold	3,048	–	–	0.42%	55
2025 Q2	$566K	Sell	3,048 -100	-3%	-$18.6K	0.35%	65
2025 Q1	$660K	Sell	3,148 -35	-1%	-$6.8K	0.45%	52
2024 Q4	$566K	Hold	3,183	–	–	0.36%	71
2024 Q3	$629K	Sell	3,183 -113	-3%	-$21.1K	0.39%	52
2024 Q2	$565K	Hold	3,296	–	–	0.36%	63
2024 Q1	$600K	Sell	3,296 -155	-4%	-$26.7K	0.36%	61
2023 Q4	$535K	Buy	+3,451	New	+$503K	0.38%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hara Capital's ABBV Position: Q2 2026 in Review

Hara Capital held its AbbVie (ABBV) position steady in Q2 2026 at 3,048 shares worth $767K. The position accounts for 0.4% of the portfolio, ranked #66.

Hara Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hara Capital held 3,048 shares of AbbVie worth $767K as of Q2 2026.
Hara Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.4% of Hara Capital's portfolio in Q2 2026, its #66 holding.
Hara Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.